over

Eightco (NASDAQ: ORBS) Reports Total Holdings of $326 Million, Includes Nearly 280 Million Worldcoin and Over 11,000 ETH

ORBS offers public market exposure to the most innovative private companies including OpenAI and Beast IndustriesORBS bridges a critical gap…

3 weeks ago

CODE27 Secures Over $10 Million in Funding to Build Immersive Interactive Character Companion Hardware

COVINA, CA, March 28, 2026 (GLOBE NEWSWIRE) -- Interactive character technology company CODE27 has completed consecutive seed and seed extension…

3 weeks ago

Over 110 Exchanges unite for this year’s Ring the Bell for Gender Equality

NEW YORK, March 6, 2026 /PRNewswire/ -- In celebration of International Women's Day on 8 March 2026, stock exchanges around…

2 months ago

MEXC Completes Rollout of Six-Tool AI Trading Suite, Reaching Over 1.5 Million Users

VICTORIA, Seychelles, March 3, 2026 /PRNewswire/ -- MEXC, the fastest-growing global cryptocurrency exchange redefining a user-first approach to digital assets through…

2 months ago

Star Health Launches 32 Arogya Seva Kendras; to Provide Primary Healthcare Access to over a Million Lives

First Arogya Seva Kendra inaugurated in Egmore, Chennai; Tamil Nadu rollout includes Nagercoil, Thoothukudi, Tiruppur and KarurStructured clinics to offer doctor…

2 months ago

Berlin Heals Successfully Raises Over 10M USD to Expand the New Less Invasive Approach to More Heart Failure Patients

ZUG, Switzerland, Feb. 12, 2026 /PRNewswire/ -- Berlin Heals Holding AG, a MedTech company focused on transformative therapies for heart failure,…

2 months ago

Are dating apps over? Gen Z is ditching ‘swipe-by’ culture for meaningful connections in the kitchen

Gen Z singles spend 156 hours per year on dating apps for only six connectionsKnorr is turning up the heat…

2 months ago

Joveos 2026 Recruiting Benchmarks Report Reveals Up to 9x Growth in Applicant Volume Over the Past Three Years

MENLO PARK, Calif., Feb. 06, 2026 (GLOBE NEWSWIRE) -- Joveo, the global leader in AI-led, high-performance recruitment marketing, today released…

2 months ago

Roches fenebrutinib is the first investigational medicine in over a decade that reduces disability progression in primary progressive multiple sclerosis (PPMS)

Late-breaking Phase III FENtrepid results presented at ACTRIMS show investigational fenebrutinib met its primary endpoint of non-inferiority compared to the…

2 months ago

January Commercial Chapter 11 Filings Increase 76% Over 2025

NEW YORK, Feb. 06, 2026 (GLOBE NEWSWIRE) -- There were 956 commercial Chapter 11 filings in January 2026, an increase…

2 months ago